140 related articles for article (PubMed ID: 34208778)
21. The Multiple Roles of Sphingomyelin in Parkinson's Disease.
Signorelli P; Conte C; Albi E
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572524
[TBL] [Abstract][Full Text] [Related]
22. 2-Hydroxypropyl-β-cyclodextrin Regulates the Epithelial to Mesenchymal Transition in Breast Cancer Cells by Modulating Cholesterol Homeostasis and Endoplasmic Reticulum Stress.
Zhao Y; He L; Wang T; Zhu L; Yan N
Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436503
[TBL] [Abstract][Full Text] [Related]
23. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Ceramide Synthesis Reduces α-Synuclein Proteinopathy in a Cellular Model of Parkinson's Disease.
Mingione A; Pivari F; Plotegher N; Dei Cas M; Zulueta A; Bocci T; Trinchera M; Albi E; Maglione V; Caretti A; Bubacco L; Paroni R; Bottai D; Ghidoni R; Signorelli P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208778
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Sphingolipid Synthesis as a Phenotype-Modifying Therapy in Cystic Fibrosis.
Mingione A; Dei Cas M; Bonezzi F; Caretti A; Piccoli M; Anastasia L; Ghidoni R; Paroni R; Signorelli P
Cell Physiol Biochem; 2020 Jan; 54(1):110-125. PubMed ID: 31999897
[TBL] [Abstract][Full Text] [Related]
26. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.
Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411
[TBL] [Abstract][Full Text] [Related]
27. Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.
Kim MJ; Jeon S; Burbulla LF; Krainc D
Hum Mol Genet; 2018 Jun; 27(11):1972-1988. PubMed ID: 29579237
[TBL] [Abstract][Full Text] [Related]
28. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
30. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.
Streubel-Gallasch L; Giusti V; Sandre M; Tessari I; Plotegher N; Giusto E; Masato A; Iovino L; Battisti I; Arrigoni G; Shimshek D; Greggio E; Tremblay ME; Bubacco L; Erlandsson A; Civiero L
Mol Neurobiol; 2021 Jul; 58(7):3119-3140. PubMed ID: 33629273
[TBL] [Abstract][Full Text] [Related]
31. Dysfunction of the SNARE complex in neurological and psychiatric disorders.
Chen F; Chen H; Chen Y; Wei W; Sun Y; Zhang L; Cui L; Wang Y
Pharmacol Res; 2021 Mar; 165():105469. PubMed ID: 33524541
[TBL] [Abstract][Full Text] [Related]
32. Myriocin modulates the altered lipid metabolism and storage in cystic fibrosis.
Signorelli P; Pivari F; Barcella M; Merelli I; Zulueta A; Dei Cas M; Rosso L; Ghidoni R; Caretti A; Paroni R; Mingione A
Cell Signal; 2021 May; 81():109928. PubMed ID: 33482299
[TBL] [Abstract][Full Text] [Related]
33. Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.
Bhat S; El-Kasaby A; Freissmuth M; Sucic S
Pharmacol Ther; 2021 Jun; 222():107785. PubMed ID: 33310157
[TBL] [Abstract][Full Text] [Related]
34. Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
Agliardi C; Meloni M; Guerini FR; Zanzottera M; Bolognesi E; Baglio F; Clerici M
Neurobiol Dis; 2021 Jan; 148():105185. PubMed ID: 33217562
[TBL] [Abstract][Full Text] [Related]
35. Sphingolipid composition of circulating extracellular vesicles after myocardial ischemia.
Burrello J; Biemmi V; Dei Cas M; Amongero M; Bolis S; Lazzarini E; Bollini S; Vassalli G; Paroni R; Barile L
Sci Rep; 2020 Sep; 10(1):16182. PubMed ID: 32999414
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
